- Home
- NVAX vs EVV Comparison
NVAX vs EVV Comparison
Compare NVAX & EVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVAX | EVV |
|---|---|---|
| Founded | 1987 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | NVAX | EVV |
|---|---|---|
| Price | $6.75 | $9.84 |
| Analyst Decision | Hold | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $9.75 | N/A |
| AVG Volume (30 Days) | ★ 3.3M | 323.7K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.66% |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.07 | N/A |
| Revenue | ★ $1,064,651,000.00 | N/A |
| Revenue This Year | $58.91 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.22 | ★ N/A |
| Revenue Growth | ★ 20.27 | N/A |
| 52 Week Low | $5.01 | $8.52 |
| 52 Week High | $11.55 | $10.07 |
Technical Indicators
Market Signals| Indicator | NVAX | EVV |
|---|---|---|
| Relative Strength Index (RSI) | 43.34 | 32.78 |
| Support Level | $6.36 | $9.94 |
| Resistance Level | $6.76 | $10.06 |
| Average True Range (ATR) | 0.22 | 0.08 |
| MACD | 0.05 | -0.02 |
| Stochastic Oscillator | 47.39 | 2.60 |
Price Performance
Historical ComparisonAbout NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest
Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund also seeks capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure, among others.